Amyotrophic lateral sclerosis ALS synonyms

Amyotrophic lateral sclerosis (ALS) is most commonly referred to by its acronym or as Lou Gehrig’s disease, though it is also historically known as Charcot’s disease in honor of the neurologist who first identified it. While these synonyms are used interchangeably in clinical and public discourse, Amyotrophic lateral sclerosis (ALS) remains the official, standardized term used by international medical organizations to describe this progressive neurodegenerative condition.

What are the historical and regional synonyms for Amyotrophic lateral sclerosis (ALS)?

The naming of Amyotrophic lateral sclerosis (ALS) has evolved significantly since its first clinical description in 1869 by Jean-Martin Charcot. In many parts of Europe, particularly in France, the condition is frequently called Charcot’s disease. In the United States, it is widely known as Lou Gehrig’s disease, a name popularized after the famous baseball player was diagnosed with the condition in 1939. Historically, older medical literature may also refer to it as motor neuron disease (MND), though in the United Kingdom and Australia, the term MND is often used as a broader umbrella term that includes Amyotrophic lateral sclerosis (ALS) as its most common subtype.

Why does Amyotrophic lateral sclerosis (ALS) have multiple names?

The use of multiple names stems from both historical context and the way different medical traditions categorize motor neuron disorders. The term "amyotrophic" refers to the muscle atrophy (wasting) that occurs, while "lateral sclerosis" describes the scarring or hardening in the lateral aspect of the spinal cord. Because the disease affects the upper and lower motor neurons, it has been historically categorized under various names depending on which clinical feature was most prominent at the time of diagnosis. Today, Amyotrophic lateral sclerosis (ALS) is the preferred clinical term because it accurately captures the pathological hallmarks identified in the central nervous system.

How is the condition classified in official medical systems?

Standardized classification systems provide a consistent framework for researchers and clinicians to track Amyotrophic lateral sclerosis (ALS) globally. These identifiers are crucial for patients when navigating health records or international research databases:

• ICD-10/ICD-11: Classified under G12.2 (Motor neuron disease).


• OMIM (Online Mendelian Inheritance in Man): Listed as #105400 (ALS1) and related entries for various genetic subtypes.


• Orphanet: Recognized as ORPHA803, categorized as a rare progressive neurodegenerative disease.


• SNOMED CT: Used in electronic health records as a specific clinical concept identifier for Amyotrophic lateral sclerosis (ALS).

Which name should patients and caregivers use?

When communicating with healthcare providers, using the formal name Amyotrophic lateral sclerosis (ALS) is the most effective way to ensure clarity and avoid confusion with other, less common motor neuron disorders. While "Lou Gehrig’s disease" is widely recognized by the general public, professional medical documentation and clinical trial protocols exclusively use Amyotrophic lateral sclerosis (ALS) to maintain diagnostic precision. Our DiseaseMaps.org community currently supports 333 members who share experiences under this diagnosis, emphasizing the importance of a unified clinical name for community support and advocacy.

Next steps

• Consult a board-certified neurologist or a neuromuscular specialist to discuss your specific clinical presentation and diagnostic findings.


• Verify your medical records use the standardized ICD-10 or ICD-11 code for Amyotrophic lateral sclerosis (ALS) to ensure accurate documentation.


• Join the DiseaseMaps.org community to connect with 333 other individuals who are managing the challenges of this diagnosis.


• Review the NIH GARD portal for updates on clinical trials and research advancements.

Medical disclaimer: This content is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• National Institutes of Health (NIH) Genetic and Rare Diseases Information Center (GARD): Amyotrophic lateral sclerosis.


• Orphanet: The portal for rare diseases and orphan drugs, ORPHA803.


• Online Mendelian Inheritance in Man (OMIM): Entry #105400.


• The ALS Association: Understanding the terminology and history of the disease.